The findings indicate that the cAMP/PKA/CREB/PTGS2 signaling pathway plays a crucial role in the antidepressant effects of AE, paving the way for its potential clinical application as a novel treatment for depression. The gene discussed is CREB1; the disease is depressive symptom measurement.